CAPR:NASDAQ
Capricor Therapeutics Inc
$7.90
arrow_downward
-1.62%(-0.13) 1D
Nov 19, 1:22:39 PM GMT-5 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CAPR...
Open
$8.04
High
$9.12
Low
$7.71
Mkt. cap
459.32M
Avg. vol.
3.75M
Volume
4.24M
52-wk high
$40.37
52-wk low
$2.96
EPS
-$2.65
Beta
0.80
Shares outstanding
58.14M
No. of employees
231
Open
$8.04
High
$9.12
Low
$7.71
Mkt. cap
459.32M
Avg. vol.
3.75M
Volume
4.24M
52-wk high
$40.37
52-wk low
$2.96
EPS
-$2.65
Beta
0.80
Shares outstanding
58.14M
No. of employees
231
News stories
From web sources and news partners
Yahoo Finance
·
1 day ago
CAPR Stock Has Retail’s Attention After SLS Rally — But 2 Other Drugs Could Have Better Estimated FDA Approval Odds This Month
Yahoo Finance
·
1 day ago
‘Pharma Bro’ Shkreli Calls SLS Results ‘Sketch,’ Compares Leukemia Vaccine Data To Capricor’s Deramiocel
Benzinga
·
2 days ago
Capricor Stock Rises: What's Going On?
About Capricor Therapeutics Inc
CEOLinda Marban
Employees231
Founded2005
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitecapricor.com
Analyst ratings
Based on 8 analysts giving stock ratings to CAPR in the past 3 months
Buy
Buy
4
Hold
4
Sell
0
12-month forecast
Based on 8 Wall Street analysts offering 12 month price targets for CAPR in the last 3 months.
Highest
Current $7.90
$54.00 (+583.54%)
Average
$27.70 (+250.63%)
Lowest
$10.50 (+32.91%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Jason McCarthy Maxim Group | Hold | Maintained | - | - | 11/13/2026 |
Boobalan Pachaiyappan Roth MKM | Hold | Reiterated | $10.50 | +32.9% | 11/13/2026 |
Madison Elsaadi B. Riley Securities | Buy | Maintained | $21.00 | +165.8% | 11/11/2026 |
Edward Tenthoff Piper Sandler | Buy | Reiterated | $25.00 | +216.5% | 11/11/2026 |
Kristen Kluska Cantor Fitzgerald | Buy | Maintained | $28.00 | +254.4% | 11/10/2026 |
Leland Gershell Oppenheimer | Buy | Maintained | $54.00 | +583.5% | 11/11/2026 |
Joseph Pantginis H.C. Wainwright | Hold | Maintained | - | - | 11/11/2026 |
Catherine Novack JonesTrading | Hold | Maintained | - | - | 09/27/2026 |
Rick Bienkowski Ladenburg Thalmann & Co. | Hold | Downgraded | - | - | 07/30/2026 |
Matthew Venezia Alliance Global Partners | Hold | Maintained | - | - | 07/30/2026 |
Unknown Analyst B. Riley Securities | Buy | Maintained | $63.00 | +697.5% | 07/27/2026 |
Unknown Analyst Alliance Global Partners | Buy | Reiterated | $51.00 | +545.6% | 03/13/2026 |
Last report
Nov 10, 2026
Fiscal period
Q3 2026
- Normalized EPS / Est. (USD)
- GAAP EPS / Est. (USD)
-$0.73 / -$0.42
-73.81%miss
arrow_downward
Revenue / Est. (USD)
- / 11.70M
Fiscal Q3 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
Revenue | - | - | - | - |
Cost of goods sold | 23.13M | 27.38M | 28.87M | 29.56M |
Cost of revenue | 23.13M | 27.38M | 28.87M | 29.56M |
Research and development expenses | - | - | - | - |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 6.02M | 9.40M | 14.08M | 15.12M |
Operating expense | 6.02M | 9.40M | 14.08M | 15.12M |
Total operating expenses | 29.16M | 36.77M | 42.95M | 44.68M |
Operating income | -29.16M | -36.77M | -42.95M | -44.68M |
Other non operating income | 11.20K | 8.14K | 2.27K | 749.00 |
EBT including unusual items | -30.17M | -33.94M | -40.73M | -42.66M |
EBT excluding unusual items | -30.17M | -33.86M | -40.73M | -42.66M |
Income tax expense | 1.60K | - | 1.60K | - |
Effective tax rate | -0.01% | - | - | - |
Other operating expenses | - | - | - | - |
Net income | -30.17M | -33.94M | -40.73M | -42.66M |
Net profit margin | - | - | - | - |
Earnings per share | -0.62 | -0.59 | -0.70 | -0.73 |
Interest and investment income | 2.02M | 2.90M | 2.21M | 2.03M |
Interest expense | -3.05M | - | - | - |
Net interest expenses | -1.02M | 2.90M | 2.21M | 2.03M |
Depreciation and amortization charges | - | - | - | - |
EBITDA | -28.65M | -36.24M | -42.38M | -43.78M |
Gain or loss from assets sale | - | - | - | - |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1
Upcoming events